Kytril Drug Information
In studies that looked at using Kytril® (granisetron hydrochloride) to prevent nausea and vomiting due to chemotherapy, up to 88 percent of people who took the drug experienced no vomiting, and up to 63 percent had no nausea within the first 24 hours after chemotherapy. The medication has also been studied for the prevention of nausea and vomiting due to radiation. In these studies, the medication significantly reduced the chance of vomiting.
The medicine comes in tablet form. It is taken by mouth, usually one hour before chemotherapy or radiation. An injectable form of Kytril is also available and is used to prevent nausea and vomiting due to chemotherapy or surgery.
Although Kytril is generally safe and effective, not everyone can use this drug. Kytril's safety information should be discussed with your healthcare provider before starting treatment to minimize risks. For example, you may not be able to use this drug if you have certain allergies, are taking certain medications, or are pregnant or breastfeeding.
(For more information on this drug, including how it works and other safety issues to discuss with your healthcare provider, click Kytril.)